These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21854868)

  • 1. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1708-19. PubMed ID: 21854868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.
    Li S; Zhou Y; Dong Y; Ip C
    Anticancer Res; 2007; 27(5A):3075-82. PubMed ID: 17970047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.
    Schulte M; Reiss K; Lettau M; Maretzky T; Ludwig A; Hartmann D; de Strooper B; Janssen O; Saftig P
    Cell Death Differ; 2007 May; 14(5):1040-9. PubMed ID: 17290285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex.
    Mohammad N; Singh SV; Malvi P; Chaube B; Athavale D; Vanuopadath M; Nair SS; Nair B; Bhat MK
    Sci Rep; 2015 Jul; 5():11853. PubMed ID: 26149967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piceatannol induces Fas and FasL up-regulation in human leukemia U937 cells via Ca2+/p38alpha MAPK-mediated activation of c-Jun and ATF-2 pathways.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1498-506. PubMed ID: 20580678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.
    Chhipa RR; Bhat MK
    J Cell Biochem; 2007 May; 101(1):68-79. PubMed ID: 17340621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
    Liu WH; Cheng YC; Chang LS
    J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters.
    Zepeda-Nuño JS; Guerrero-Velázquez C; Del Toro-Arreola S; Vega-Magaña N; Ángeles-Sánchez J; Haramati J; Pereira-Suárez AL; Bueno-Topete MR
    Pathol Oncol Res; 2017 Apr; 23(2):345-353. PubMed ID: 27628319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma.
    Yang CL; Jiang FQ; Xu F; Jiang GX
    Tumour Biol; 2012 Oct; 33(5):1535-41. PubMed ID: 22581584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.
    Zhong Y; Zhang F; Sun Z; Zhou W; Li ZY; You QD; Guo QL; Hu R
    Mol Carcinog; 2013 Oct; 52(10):824-34. PubMed ID: 22593043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Fas and FasL in Taiwan cobra phospholipase A2-treated human neuroblastoma SK-N-SH cells through ROS- and Ca2+-mediated p38 MAPK activation.
    Chen KC; Kao PH; Lin SR; Chang LS
    J Cell Biochem; 2009 Jan; 106(1):93-102. PubMed ID: 19009558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death.
    Kim HS; Lee YS; Kim DK
    Pharmacology; 2009; 84(5):300-9. PubMed ID: 19829019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
    Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
    Ebsen H; Lettau M; Kabelitz D; Janssen O
    Mol Immunol; 2015 Jun; 65(2):416-28. PubMed ID: 25745808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Park SJ; Wu CH; Safa AR
    Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
    Mitsiades N; Yu WH; Poulaki V; Tsokos M; Stamenkovic I
    Cancer Res; 2001 Jan; 61(2):577-81. PubMed ID: 11212252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmitoylation of human FasL modulates its cell death-inducing function.
    Guardiola-Serrano F; Rossin A; Cahuzac N; Lückerath K; Melzer I; Mailfert S; Marguet D; Zörnig M; Hueber AO
    Cell Death Dis; 2010 Oct; 1(10):e88. PubMed ID: 21368861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
    Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
    Liu WH; Chang LS
    Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.